This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Heinz Hasler: Innovator in Thiazolidine Derivatives
Introduction
Heinz Hasler is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on thiazolidine derivatives. His research focuses on developing compounds that can aid in the treatment of metabolic disorders.
Latest Patents
Heinz Hasler holds a patent for novel thiazolidine derivatives. The invention relates to compounds of the formula ##STR1## wherein X is methylene, oxygen, or sulfur; R¹ is halogen; R² is hydrogen, nitro, cyano, OR³, or NHR³; or R¹ and R² both simultaneously are hydrogen or nitro; R³ is hydrogen, alkyl, acyl, --CO--OR⁴, or --CO--NHR⁴; and R⁴ is alkyl, unsubstituted or substituted aryl or aralkyl, along with their salts with physiologically compatible cations. These compounds are particularly useful in addressing metabolic disorders.
Career Highlights
Heinz Hasler is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Heinz Hasler has collaborated with Fernand Schneider, enhancing the research and development efforts in their field.
Conclusion
Heinz Hasler's innovative work on thiazolidine derivatives showcases his commitment to improving healthcare through scientific research. His contributions are vital in the ongoing quest to find effective treatments for metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile